期刊文献+

特比萘芬成功治愈误诊为曲霉感染的皮肤利什曼病一例 被引量:5

A case of cutaneous leishmaniasis misdiagnosed as cutaneous aspergillosis and successfully treated with terbinafine
原文传递
导出
摘要 患儿女,5岁,内蒙古人。左面颊皮疹10个月。起病前数周局部曾被犬抓伤,初起为无症状小红丘疹,渐扩大。皮屑镜检见分支分隔菌丝,皮屑培养示阿姆斯特丹散囊菌(曲霉有性期),初诊为皮肤曲霉感染。给予伊曲康唑200mg,d治疗2个月,疗效欠佳。组织病理检查及瑞氏-吉姆萨染色,见真皮及皮下组织细胞内外大量利-杜小体,PAS染色未见真菌成分,组织真菌培养阴性,确诊为皮肤利什曼病。给予特比萘芬125mg/d治疗2个月后皮疹痊愈。 A 5-year-old Mongolian girl from Inner Mongolia presented with a painless, round skin lesion on the left cheek for 10 months. Several weeks prior to the development of lesions, her left cheek was scratched by a dog. Subsequently, small asymptomatic erythematous papules developed at the scratched site and gradually enlarged. Direct microscopy of scales from the lesions revealed septate, branching hyphae and fungal culture grew Eurotium amstelodami (perfect stage of aspergillus). She was initially diagnosed as cuta- neous aspergillosis and treated with itraconazole 200 mg per day for 2 months, but limited improvement was achieved. Histopathologieal examination with Wright-Giemsa staining of skin biopsies revealed abundant leishman l)onovani bodies intracellularly and extracellularly in the dermis and subcutaneous tissue; PAS staining of tissue specimens showed no fungal element and fungal culture was negative. She was finally diagnosed with cutaneous leishmaniasis. After treatment with terbinafine 125 mg per day for 2 months, the lesion subsided.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2011年第11期811-813,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献9

  • 1Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther, 2010, 8(4): 419-433.
  • 2Geiser DM, Klich MA, Frisvad JC, et al. The current status of species recognition and identification in Aspergillus. Stud Mycol, 2007, 59: 1-10.
  • 3Butinm" L, Zalar P, Frisvad JC, et al. The genus Eurotium- members of indigenous fungal community in hypersaline waters of saltems. FEMS Microbiol Ecol, 2005, 51 (2): 155-166.
  • 4Allen CM Jr. Isoprene-containing metabolites of Aspergillus amstelodami. Can J Microbiol, 1972, 18(8): 1275-1282.
  • 5Sampaio RN, Takano GI~ Malacame AC, et al. In vivo terbinafine inefficacy on cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis in C57BL/6 mice. Rev Soc Bras Med Trop, 2003, 36(4): 531-533.
  • 6Vannier-Santos MA, Urbina JA, Martiny A, et al. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania. J Eukaryot Microbiol, 1995, 42(4): 337-346.
  • 7Balfour JA, Faulds D. Terbinafin~ A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs, 1992, 43(2): 259-284.
  • 8Rangel H, Dagger F, Hemandez A, et al. Naturally azole-resistant Leishmania brzziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole- susceptible Leishmania mexicana promastigotes. Antimicrob Agents Chemother, 1996, 40 (12): 2785-2791.
  • 9Gonzdlez-Rup6rez J, Javaloyas de Morlius M, Moreno Carazo A. Remis- sion: of localized cutaneous leishmaniasis in a HIV-positive patient using systemic terbiuafine. Dermatology, 1997, 194 ( 1 ): 85-86.

同被引文献22

  • 1Nisha Singh,Manish Kumar,Rakesh Kumar Singh.Leishmaniasis:Current status of available drugs and new potential drug targets[J].Asian Pacific Journal of Tropical Medicine,2012,5(6):485-497. 被引量:5
  • 2杨元清,管立人.克拉玛依地区28例皮肤利什曼病的临床病理观察[J].中国寄生虫学与寄生虫病杂志,1994,12(3):182-184. 被引量:4
  • 3李志军,刘流,何黎.外用咪喹莫特的研究进展[J].国际皮肤性病学杂志,2006,32(3):144-146. 被引量:17
  • 4高莹,陈声利,孙建方.皮肤利什曼病二例[J].中华皮肤科杂志,2006,39(11):673-673. 被引量:2
  • 5朱学骏,王宝玺,孙建方,等.皮肤病学[M].北京:北京大学医学出版社,2011:482-486.
  • 6Ameen M. Cutaneous leishrnaniasis: advances in disease patho- genesis, diagnostics and therapeutics. Clin Exp Dermatol, 2010, 35(7): 699-705.
  • 7Andrade-Narvaez FJ, Medina-Peralta S, Vargas-Gonzalez A, et al. The histopathology of cutaneous leishmaniasis due to Leish- mania (Leishmania) mexicana in the Yucatan peninsula, Mexico. Rev Inst Med Trop San Paulo, 2005, 47(4): 191-194.
  • 8Reithinger R, Dujardin JC. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol, 2007, 45 ( 1 ): 21-25.
  • 9Kar K. Serodiagnosis of leishmaniasis. Crit Rev Microbiol, 1995, 21(2): 123-152.
  • 10Reed SG, Scott P. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol, 1993, 5(4): 524-531.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部